Clinical Trials in Kemerovo, Kemerovo Oblast
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800
Recruiting
Post-market Clinical Monitoring of the Safety and Efficacy of the Aortic Valve Bioprothesis
Aortic Valve DiseaseArtificial Heart Valves
Closed Joint-Stock Company NeoCor2,000 enrolled1 locationNCT05998694